I n this issue of Clinical Gastroenterology and Hepatology, Keswani et al review the published data on the correlation between the outcomes of endoscopic retrograde cholangiopancreatography (ERCP) and the case volumes of the endoscopists (ERCPists) and centers. They confirmed that more is better, concluding that they propose that providers and payers consider consolidating ERCP to high-volume endoscopists to improve ERCP outcomes and value. Unfortunately, they provide no guidance on what that volume should be, or how consolidation might occur. I offer some suggestions, not for the first time. 1 
What Is ERCP?
When ERCP was named in 1972 (by me), it accurately described the revolutionary new diagnostic technique for making radiographs of the biliary and pancreatic ducts. ERCP is now rarely used purely for diagnosis, and has evolved into a comprehensive therapeutic platform, with multiple potential applications varying in clinical and technical complexity. An American Society for Gastrointestinal Endoscopy (ASGE) workshop recommended four levels of complexity, 2 which can be condensed practically into 3: standard, advanced, and advanced tertiary (Table 1) . We focus initially on the Standard interventions, as they are the most common, usually effective, and should be widely available in the community.
What Is an Adequate Volume?
The articles that Keswani et al. reviewed defined lowvolume endoscopists from <27 cases/year up to <156 cases/year. Experts discussing this topic probably guess somewhere closer to 50 cases/year, although that number was reported in 2011 to be achieved by less than half of the ERCPists in the United States. 3 Center volume is also relevant, as is well known in the surgical world. A minimal volume is required to ensure the necessary facilities, equipment, and staff. The articles cited by Keswani et al defined low center volume as 87-200 cases/year. However, it was reported in 2006 that half of U.S. hospitals performed <50 ERCP procedures/year. 4 The British Society of Gastroenterology proposed a minimum of 150 ERCP procedures/year. 5 Numbers are easy to count, but alone are poor surrogates for performance, which is influenced by the extent of training, the spectrum of practice, and lifetime experience. Someone with extensive training, and thousands of cases, may perform well for a while with small annual volumes, whereas someone just out of (marginal) training will likely struggle. Their performance will also be influenced by the center volume.
What Are the Real Measures of Quality, and Acceptable Thresholds?
Quality means doing the right thing and doing it right. Professional societies publish guidelines for "doing the right thing" (indications) but they are broad and include caveats which permit almost anything. Furthermore, the field continues to develop, as surgical and radiological techniques improve and as careful research studies look more closely at outcomes. For instance, the Evaluating Predictors and Interventions in Sphincter of Oddi Dysfunction (EPISOD) study showed that a popular procedure-sphincterotomy for Sphincter of Oddi Dysfunction type III (SOD III)-was no more helpful than a sham intervention. 6 Good measures for "doing it right" for the common biliary procedures include rates for biliary cannulation (in virgin papillae), for extracting small stones, and for placing stents to treat low biliary strictures and leaks. Experts can achieve these measures in over 95% of cases, but not all patients can be treated by experts. What would you, the reader, be comfortable with as a patient? The ASGE/American College of Gastroenterology Taskforce on Quality in Endoscopy suggested a success rate of 85% or higher in 2006, 7 updated to >90% in 2015. 8 The British Society of Gastroenterology suggests 85% for cannulation, 75% for stones, and 80% for stenting. 5 A Dutch survey found an average success rate of 86% for biliary procedures, with the rate dropping quickly for those doing less than 50 procedures/year. 9 Would you settle for less than 85%? No one would accept a cecal intubation rate of 85% for screening colonoscopy. Of course, this presupposes that patients have the data with which to choose. Good technique should also result in a low postprocedure pancreatitis rate, which should be <5% in biliary indications.
The quality metrics, and acceptable success rates, will be different for advanced procedures. Few can claim >80% cannulation of the bile duct after surgical biliary diversions, or of the minor papilla when indicated, or when placing bilateral stents in hilar strictures. Equally, the post-ERCP pancreatitis rate will be well above 5% in many advanced contexts, even in the best of hands.
The ideal quality metric is whether the procedure fixes the clinical problem. That is difficult to assess outside structured research projects. One measure of failure is the need for the procedure to be repeated, or complemented by an alternative.
should collect their performance data, and have it available when requested by privileging bodies, payers, patients (and plaintiff lawyers). Some individuals and practices do so, but "report cards" have not become popular, as there is currently no pressing motivation. Some years ago I set up the voluntary ERCP Quality Network, to which endoscopists could upload and benchmark their data. 10 The pilot was discontinued when it appeared that the Gastrointestinal Quality Improvement Consortium (GIQuIC), which does essentially the same thing for colonoscopy, seemed poised to include an ERCP platform. 11 Sadly, that has not yet happened. The GIQuIC system is also voluntary, but it is increasingly popular and is being recognized by national quality bodies.
Who Should Control the Quality of ERCP?
There is little point in discussing or collecting quality data unless action follows. Some countries have formal national organizations, which ensure that only competent ERCPists can practice. The multisociety Conjoint Committee for the Recognition of Training in Gastrointestinal Endoscopy has a list of certified endoscopists (by technique) that hospitals use to award privileges. 8 The professional organizations in the United States advise on quality issues and issue guidelines, but have no real power. The authority lies with the individual hospitals, whose credentialing committees issue privileges to practice. A recent survey shows that this responsibility is handled poorly in many hospitals; 21% of responding gastroenterologists stated that their hospitals had no written guidelines for initial credentialing, and 59% had none for recredentialing. 11 Why do some hospitals not seem to care, despite the obvious (and proven) medicolegal risk involved? 12 In the United States, the Joint Commission does have authority over the quality of hospital activities, but the survey data show that their inspectors do not always drill down to this level. Maybe ERCP is too small an item in their portfolio, or that they (and others) fail to recognize that ERCP is dramatically more dangerous than all of the other common endoscopic procedures.
Why Do Some Very Low-Volume ERCPists Persist?
No doubt many choose their cases carefully and have good results. Some may think that they are doing a good job, but have not kept up with the major changes that have occurred in the field. One reason, apparently, why some continue to practice ERCP at low volumes is to provide emergency services without overburdening their colleagues in their group. Clearly, the answer is for several practices to collaborate to provide a roster of skilled individuals. They would be forced to do so if hospitals were less generous with privileges.
Advanced Procedures
Early ERCPists, such as myself, assumed that the success we had with the initial biliary treatments would transfer easily into pancreatic indications. These have proved to be more difficult technically, often more dangerous, and some less effective. Not all ERCPists or centers should be attempting them. ASGE should develop a system for recognizing (or certifying) advanced ERCPists, such as the expanding STAR (Skills Training Assessment Reinforcement) program, which focus on lower-volume high-tech procedures such as endoscopic mucosal resection. 13 
Conclusions
ERCP is now a wide spectrum of therapeutic procedures of varying complexity and risk, requiring extensive training and serious focus in practice. Patients being offered an ERCP procedure in the United States deserve to know that their practitioners are competent. Current arrangements do not provide that guarantee. I offer some recommendations.
Recommendations
1. Hospital credentialing committees should have guidelines for credentialing and recredentialing. Decisions will be influenced by the knowing the 
